Canada and the Global Fund to Fight AIDS, Tuberculosis and Malaria
The Global Fund to Fight AIDS, Tuberculosis and Malaria was created by the international community in 2002. Its goal is to dramatically increase resources to fight 3 of the world's most devastating diseases:
- HIV/AIDS
- tuberculosis
- malaria
The Global Fund is a partnership between governments, civil society, the private sector and people affected by the diseases. It supports large-scale prevention, treatment and care programs run by local experts in countries and communities most in need. The Global Fund takes a country-led approach, with national governments and local organizations leading program design and implementation.
Since 2002, the Global Fund has saved an estimated 65 million lives.
Despite this progress, there is still much to be done.
In 2023:
- about 10.8 million people fell ill with tuberculosis.
- it killed 1.25 million people
- more than 161,000 of those had HIV
- nearly 514,000 people died of HIV-related illnesses
- 932,000 people became newly infected with HIV
In 2022:
- 249 million people contracted malaria
- about 608,000 of them died
Most at risk are women and girls, and populations living in vulnerable situations, such as:
- men who have sex with men
- drug users
- sex workers
- transgender people
- those who live in poverty
Barriers to human rights prevent millions of people from accessing prevention, treatment and care.
People are also being denied access to health care due to:
- stigma
- discrimination
- gender inequality
- violence
- harmful social norms
Canada's support for the Global Fund
Canada has supported the Global Fund since its inception and is its sixth-largest government donor. Canada has also been a consistently strong voice on the Global Fund Board.
Canada's support of the Global Fund focuses on the following priorities:
- Combat HIV/AIDS, tuberculosis and malaria
- Reduce child mortality
- Improve the health and rights of women and children
- Promote human rights in the context of HIV/AIDS, tuberculosis and malaria.
Thanks to the support of donors like Canada, in countries where the Global Fund invests, there has been a full recovery from the disruptive impacts of the COVID-19 pandemic on the responses to the three diseases.
HIV/AIDS
- 25 million people are receiving life-saving antiretroviral treatment for HIV/AIDS
- 17.9 million people were reached in 2023 with HIV prevention programs
- 53.8 million people were tested for HIV in 2023
- 695,000 HIV-positive pregnant women received antiretroviral drugs preventing HIV transmission to their infants in 2023
- 925,000 medical circumcisions were performed to prevent HIV in 2023
- Through market shaping efforts, the Global Fund secured a further 20% reduction in the cost of antiretroviral medicines in 2023
Tuberculosis
- 7.1 million new cases of infectious tuberculosis were detected and treated in 2023
- 121,000 cases of multi-drug-resistant tuberculosis were treated in 2023
- 2 million people in contact with TB patients received preventive therapy in 2023
Malaria
- 227 million insecticide-treated mosquito nets were distributed to protect families from transmission in 2023
- 335 million people were tested for malaria in 2023
- 7.9 million structures were sprayed with insecticide to protect people from malaria in 2023
- 15.5 million pregnant women received preventive therapy in 2023
Related links
Report a problem on this page
- Date modified: